查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1604496

精準治療人工智慧（AI）市場：未來預測（2024-2029）

Artificial Intelligence (AI) In Precision Therapies Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 146 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

精準醫療人工智慧（AI）市場預計將以27.56%的複合年成長率成長，2029年市場規模達到75.06億美元，2024年市場規模達到22.23億美元。

精準醫療人工智慧市場是一種獨特的顛覆性方法，正在徹底改變個人化醫療和患者照護。個體化醫療根據每位患者的遺傳、生活方式和疾病特徵量身定做治療方案，旨在實現最佳效果，同時最大限度地減少副作用。該領域正在迅速利用人工智慧技術來探索潛在的生物標記、藥物作用目標、治療方案、低效的資料管理、患者分層等。正確的人工智慧技術可以處理大量患者記錄、遺傳資訊和臨床試驗結果，幫助醫療保健提供者針對患者進行藥物和治療。

精準醫療的人工智慧市場前景廣闊，因為它有潛力重塑醫療領域，實現更有效、以病人為中心的照護。

精準治療的人工智慧 (AI) 市場驅動力

  • 個人化醫療和精準醫療的不斷成長趨勢正在推動精準醫療人工智慧 (AI) 市場的成長。

隨著個人化醫療和精準醫療的變革，人工智慧技術擴大被應用於精準治療。這些變化凸顯了針對具有不同遺傳傾向、生活方式和疾病特徵的不同患者客製化醫療干預措施的重要性。新技術和分子生物學已經能夠識別各種生物標記和治療靶點，使治療更加精確和特異性。人工智慧對於透過基因組學、臨床資料和即時患者資訊等廣泛資料集集來預測治療反應和疾病結果至關重要。人們越來越重視個人化醫療和精準醫療的有效性，以促進積極的患者治療結果，從而增加了基於人工智慧的系統在精準醫療中的採用。

精準治療的人工智慧 (AI) 市場：地理視角

  • 北美在預測期內將經歷指數級成長

美國在精準醫療和治療領域人工智慧技術的研究、開發和使用方面處於主導。北美的領先優勢並不令人意外，因為其醫療設施完善、人工智慧資金水平高、以及大型製藥和生物技術公司。此外，該地區個人化和精準醫療的整體趨勢正在塑造人工智慧解決方案的市場，以改善治療和患者的治療結果。人工智慧技術的進步必將確保北美繼續佔據精準醫療人工智慧市場的最大佔有率。

為什麼要購買這份報告？

  • 富有洞察力的分析：獲得涵蓋主要和新興地區的深入市場洞察，重點關注客戶細分、政府政策和社會經濟因素、消費者偏好、行業明智以及其他子區隔。
  • 競爭格局：了解世界主要企業採取的策略策略，並了解透過正確的策略滲透市場的潛力。
  • 市場促進因素和未來趨勢：探索動態因素和關鍵市場趨勢以及它們將如何影響未來市場發展。
  • 可行的建議：利用洞察力做出策略決策，以在動態環境中發現新的業務流和收益。
  • 受眾廣泛：對於新興企業、研究機構、顧問、中小企業和大型企業有用且具有成本效益。

它有什麼用？

產業與市場考量、商機評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範與影響、新產品開發、競爭影響

分析範圍

  • 歷史資料與預測（2022-2029）
  • 成長機會、挑戰、供應鏈前景、法規結構、顧客行為、趨勢分析
  • 競爭對手定位、策略和市場佔有率分析
  • 收益成長率與預測分析：按細分市場/地區（按國家）
  • 公司概況（策略、產品、財務資訊、主要趨勢等）

目錄

第1章簡介

  • 市場概況
  • 市場定義
  • 分析範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關利益者的主要利益

第2章 分析方法

  • 分析設計
  • 分析過程

第3章執行摘要

  • 主要發現
  • CXO觀點

第4章市場動態

  • 市場促進因素
  • 市場限制因素
  • 波特五力分析
  • 產業價值鏈分析
  • 分析師觀點

第5章精準治療的人工智慧（AI）市場：按治療類型

  • 介紹
  • 個人化醫療
  • 標靶治療
  • 基因治療
  • 細胞療法
  • 免疫療法
  • 其他

第6章精準治療人工智慧（AI）市場：依應用分類

  • 介紹
  • 瘤
  • 神經系統疾病
  • 心臟病
  • 感染疾病
  • 罕見疾病
  • 自體免疫疾病
  • 其他

第7章終端使用者產業精準治療的人工智慧（AI）市場

  • 介紹
  • 醫院/診所
  • 製藥和生物技術公司
  • 研究機構/學術中心
  • 其他

第8章精準治療的人工智慧（AI）市場：按地區

  • 介紹
  • 北美洲
    • 按治療類型
    • 按用途
    • 按最終用戶產業
    • 按國家/地區
  • 南美洲
    • 按治療類型
    • 按用途
    • 按最終用戶產業
    • 按國家/地區
  • 歐洲
    • 按治療類型
    • 按用途
    • 按最終用戶產業
    • 按國家/地區
  • 中東/非洲
    • 按治療類型
    • 按用途
    • 按最終用戶產業
    • 按國家/地區
  • 亞太地區
    • 按治療類型
    • 按用途
    • 按最終用戶產業
    • 按國家/地區

第9章競爭環境及分析

  • 主要企業及策略分析
  • 市場佔有率分析
  • 企業合併（M&A）、合約、業務合作
  • 競爭對手儀表板

第10章 公司簡介

  • IBM Watson Health (IBM Corporation)
  • Google Health (Alphabet Inc.)
  • Tempus Labs, Inc.
  • Nvidia Corporation
  • Deep Genomics, Inc.
  • Microsoft Corporation
  • Owkin, Inc.
  • Benevolentai Ltd.
  • Recursion Pharmaceuticals, Inc.
  • Cloud Pharmaceuticals, Inc.
簡介目錄
Product Code: KSI061615866

Artificial intelligence (AI) in the precision therapies market is expected to grow at a CAGR of 27.56%, reaching a market size of US$7.506 billion in 2029 and US$2.223 billion in 2024.

AI in the precision therapies market is a unique and disruptive method that is revolutionizing personalized medicine and patient care. Custom-made medication aims to tailor medical treatments to individual patients' genetics, way of life, and disease characteristics to achieve the best results with the least side complications. Within this field, the application of AI technology has become much faster in exploring potential biomarkers, targets for drug action, options for treatment, and inefficient data management and stratification of patients. Suitable AI techniques can handle large volumes of patient records, genetic information, and outcomes from clinical trials, thus assisting healthcare providers in administering their patients with targeted medications and therapies.

The market of AI in precision therapies is considerably promising in that it could reshape the healthcare sector into more effective and patient-oriented therapies.

Artificial intelligence (AI) in the precision therapies market drivers?

  • Rising trends in personalized and precision medicine are increasing the Artificial Intelligence (AI) in precision therapies market growth.

AI technologies employed in precision therapies are rising due to changes in personalized and precision medicine. These changes stress the importance of customizing medical interventions to different patients who have varying genetic makeups, lifestyles, and disease characteristics. New technologies and molecular biology have made identifying various biomarkers and therapeutic targets possible, making treatment more accurate and specific. AI is pivotal in predicting treatment responses and disease outcomes through extensive datasets such as genomes, clinical data, and real-time patient information. The growing emphasis on the effectiveness of personalized or precision medicine in promoting positive patient outcomes has led to increased uptake of AI-based systems in precision therapeutics.

Artificial intelligence (AI) in the precision therapies market - geographical outlook

  • North America is witnessing exponential growth during the forecast period

The US has led the research, development, and use of AI technology in precision medicine and therapeutics. It is not surprising that North America leads due to its well-established healthcare facilities, high-level AI funding, and large-scale pharmaceutical and biotech companies. In addition, the region's general trend towards personalized medicine and precision healthcare has created a market for AI-infused solutions that enhance treatment and patient outcomes. Advances in AI technologies will ensure that North America remains the largest shareholder in AI in the precision therapies market.

Reasons for buying this report:-

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data & forecasts from 2022 to 2029
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The Artificial Intelligence (AI) in precision therapies market is segmented and analyzed as follows:

By Therapy Type

  • Personalized Medicine
  • Targeted Therapies
  • Gene Therapies
  • Cell Therapies
  • Immunotherapies
  • Others

By Application

  • Oncology
  • Neurology
  • Cardiology
  • Infectious Diseases
  • Rare Diseases
  • Autoimmune Diseases
  • Others

By End-User Industry

  • Hospitals And Clinics
  • Pharmaceutical And Biotechnology Companies
  • Research Institutes And Academic Centers
  • Others

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. CXO Perspective

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. ARTIFICIAL INTELLIGENCE (AI) IN PRECISION THERAPIES MARKET BY THERAPY TYPE

  • 5.1. Introduction
  • 5.2. Personalized Medicine
  • 5.3. Targeted Therapies
  • 5.4. Gene Therapies
  • 5.5. Cell Therapies
  • 5.6. Immunotherapies
  • 5.7. Others

6. ARTIFICIAL INTELLIGENCE (AI) IN PRECISION THERAPIES MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Oncology
  • 6.3. Neurology
  • 6.4. Cardiology
  • 6.5. Infectious Diseases
  • 6.6. Rare Diseases
  • 6.7. Autoimmune Diseases
  • 6.8. Others

7. ARTIFICIAL INTELLIGENCE (AI) IN PRECISION THERAPIES MARKET BY END-USER INDUSTRY

  • 7.1. Introduction
  • 7.2. Hospitals And Clinics
  • 7.3. Pharmaceutical And Biotechnology Companies
  • 7.4. Research Institutes And Academic Centers
  • 7.5. Others

8. ARTIFICIAL INTELLIGENCE (AI) IN PRECISION THERAPIES MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Therapy Type
    • 8.2.2. By Application
    • 8.2.3. BY End-User Industry
    • 8.2.4. By Country
      • 8.2.4.1. United States
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Therapy Type
    • 8.3.2. By Application
    • 8.3.3. BY End-User Industry
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Therapy Type
    • 8.4.2. By Application
    • 8.4.3. BY End-User Industry
    • 8.4.4. By Country
      • 8.4.4.1. United Kingdom
      • 8.4.4.2. Germany
      • 8.4.4.3. France
      • 8.4.4.4. Italy
      • 8.4.4.5. Spain
      • 8.4.4.6. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Therapy Type
    • 8.5.2. By Application
    • 8.5.3. BY End-User Industry
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. UAE
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Therapy Type
    • 8.6.2. By Application
    • 8.6.3. BY End-User Industry
    • 8.6.4. By Country
      • 8.6.4.1. Japan
      • 8.6.4.2. China
      • 8.6.4.3. India
      • 8.6.4.4. South Korea
      • 8.6.4.5. Taiwan
      • 8.6.4.6. Thailand
      • 8.6.4.7. Indonesia
      • 8.6.4.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. IBM Watson Health (IBM Corporation)
  • 10.2. Google Health (Alphabet Inc.)
  • 10.3. Tempus Labs, Inc.
  • 10.4. Nvidia Corporation
  • 10.5. Deep Genomics, Inc.
  • 10.6. Microsoft Corporation
  • 10.7. Owkin, Inc.
  • 10.8. Benevolentai Ltd.
  • 10.9. Recursion Pharmaceuticals, Inc.
  • 10.10. Cloud Pharmaceuticals, Inc.